Join Now Why Join?
Log In or Login with Facebook
Symbol Search  
or enter GC* - Gold Futures
Quotes and Charts
YOU ARE HERE:  Stocks » Quotes and Charts » News Headlines
+ Alert
+ Portfolio

Vertex Pharmaceuticals Inc. (VRTX)

77.38-2.11 (-2.65%) 8:10P EDT (NASDAQ)
Price Quote as of Monday, May 20th, 2013

Latest Vertex Pharmaceuticals Inc. (VRTX) Headlines

74.7% Return Seen to Date on SmarTrend Vertex Pharmaceuticals Call (VRTX)

Comtex SmarTrend(R) - Mon May 20, 4:42PM CDT
SmarTrend identified an Uptrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on January 3rd, 2013 at $44.30. In approximately 5 months, Vertex Pharmaceuticals has returned 74.67% as of today's recent price of $77.38. (full story)

Earnings Look Back: Vertex Pharmaceuticals Is Up 3.5% Since Reporting Quarterly Results 2 Weeks Ago (VRTX)

Comtex SmarTrend(R) - Mon May 20, 12:15PM CDT
When Vertex Pharmaceuticals (NASDAQ:VRTX) reported earnings 20 days ago on April 30th, 2013, analysts, on average, expected the company to report a loss of $0.07 on sales of $309.0 million. Vertex Pharmaceuticals actually reported earnings of $0.03 per share on sales of $328.4 million, beating EPS estimates by $0.10 and beating revenue estimates by $19.4 million. Since the company's report, shares of Vertex Pharmaceuticals have risen from $76.82 to $79.49, representing a gain of 3.5% in the past 20 days. (full story)

Vertex Pharmaceuticals Incorporated to redeem USD400m convertible senior subordinated notes

M2 - Mon May 20, 11:16AM CDT
Medicine company Vertex Pharmaceuticals Incorporated (NasdaqGS:VRTX) stated on Friday that it will redeem its outstanding USD400.0m in aggregate principal amount of 3.35% convertible senior subordinated notes due 2015. (full story)

Vertex Calls for Redemption of $400 Million in Convertible Senior Subordinated Notes Due 2015

Business Wire - Fri May 17, 7:30AM CDT
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) announced that it has called for redemption of its outstanding $400.0 million in aggregate principal amount of 3.35% Convertible Senior Subordinated Notes due 2015, pursuant to the provisional "soft call" redemption right in the indenture governing the 2015 Notes. Any 2015 Notes outstanding on June 17, 2013 will be redeemed in cash for 100% of the principal amount, plus a make-whole interest payment of $16.75 per $1,000 principal amount payable in shares of Vertex's common stock. The 2015 Notes are convertible on or before June 14, 2013 into shares of Vertex's common stock at a conversion price of approximately $48.83 per share (20.4794 shares per $1,000 principal amount). Holders of 2015 Notes that are submitted for conversion into common stock on or before June 14, 2013 also will receive the make-whole interest payment. On May 16, 2013, the closing price for (full story)

Look for Shares of Vertex Pharmaceuticals to Potentially Pullback after Yesterday's 4.75% Rise

Comtex SmarTrend(R) - Fri May 10, 4:04PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $76.53 to a high of $81.04. Yesterday, the shares gained 4.8%, which took the trading range above the 3-day high of $79.41 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Look for Shares of Vertex Pharmaceuticals to Potentially Pullback after Yesterday's 4.75% Rise

Comtex SmarTrend(R) - Fri May 10, 4:03PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $76.53 to a high of $81.04. Yesterday, the shares gained 4.8%, which took the trading range above the 3-day high of $79.41 on volume of 2.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Vertex Pharmaceuticals Announces Webcasts of its Presentations at Two Investor Conferences

Business Wire - Thu May 09, 5:07PM CDT
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex will webcast its presentations at the Bank of America Healthcare conference on Tuesday, May 14, 2013 at 3:40 PM PT and at the Sanford Bernstein Strategic Decisions conference on Wednesday, May 29, 2013 at 2:00 PM ET. (full story)

Vertex Pharmaceuticals Up 70.3% Since SmarTrend Uptrend Call (VRTX)

Comtex SmarTrend(R) - Wed May 08, 4:35PM CDT
SmarTrend identified an Uptrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on January 3rd, 2013 at $44.30. In approximately 4 months, Vertex Pharmaceuticals has returned 70.27% as of today's recent price of $75.43. (full story)

Gilead Sciences climbs to all-time highs

AP - Fri May 03, 3:56PM CDT
NEW YORK (AP) — Shares of Gilead Sciences Inc. rose to all-time highs Friday after the company reported its first-quarter results and new trial data for two of its experimental hepatitis C drugs. (full story)

EPR adds FB, ARNA and VRTX to their Nasdaq Active Stock Watch List

ACCESSWIRE-TNW - Fri May 03, 10:08AM CDT
New York, NY -- (ACCESSWIRE) -- 05/3/2013 -- Equity Profile Report expands its NASDAQ Active Stock Watch List adding Facebook, Inc. (NASDAQ:FB), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) (full story)

Shares of VRTX Up 77.5% Since Uptrend Call on Shares

Comtex SmarTrend(R) - Wed May 01, 10:50AM CDT
SmarTrend identified an Uptrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on January 3rd, 2013 at $44.30. In approximately 4 months, Vertex Pharmaceuticals has returned 77.47% as of today's recent price of $78.62. (full story)

Vertex Loss Lower, Kalydeco Outlook Up - Analyst Blog

Zacks Equity Research - Zacks Investment Research - Wed May 01, 8:52AM CDT
Vertex raised its outlook for Kalydeco revenues by $20 million to $300 million - $340 million. (full story)

AFFY, AMGN, VRTX, and QCOR Early Briefing and Review

ACCESSWIRE-TNW - Wed May 01, 6:56AM CDT
StockCall.com Provides Stock Research on Affymax Inc., Amgen Inc., Vertex Pharmaceuticals Inc., and Questcor Pharmaceuticals Inc. (full story)

Vertex Pharmaceuticals Set to Possibly Rebound After Yesterday's Selloff of 1.93%

Comtex SmarTrend(R) - Tue Apr 30, 4:01PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $75.96 to a high of $78.04. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $78.25 on volume of 3.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story)

Watch for Vertex Pharmaceuticals to Potentially Rebound After Falling 1.93% Yesterday

Comtex SmarTrend(R) - Tue Apr 30, 4:01PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $75.96 to a high of $78.04. Yesterday, the shares fell 1.9%, which took the trading range below the 3-day low of $78.25 on volume of 3.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story)

Vertex Reports First Quarter 2013 Financial Results and Reviews Recent Progress in Development Programs for Cystic Fibrosis and Hepatitis C

Business Wire - Tue Apr 30, 3:03PM CDT
---Cystic fibrosis: Enrollment ongoing in Phase 3 program for VX-809 in combination with ivacaftor for people with two copies of the F508del mutation- (full story)

WSH, APU, VRTX, EZPW, HCBK, LOOK Expected To Be Down After Next Earnings Releases

M2 - Mon Apr 29, 4:05AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the performance of all stocks with earnings being released Tuesday, April 30th 2013 and determining how the stocks have performed After their last 12 quarterly, 6 quarterly and June earnings reports. Willis Group Holdings PLC (NYSE:WSH), Amerigas Partners LP (NYSE:APU), VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX), EZCORP Inc (NASDAQ:EZPW), Hudson City Bancorp Inc (NASDAQ:HCBK), Looksmart Ltd (NASDAQ:LOOK) are all expected to be Down After their earnings are released. The movement of stock prices in the days and weeks leading to and following these earnings announcements may follow a predictable pattern. Most companies stock price histories show random or unpredictable movements around earnings dates. But some seem to repeat the same pattern quarter after quarter, year after year. The # of Reports in the table below shows how many previous quarterly reports comprise the indicator that predicts how a stock will act after its earnings are released. The specific te (full story)

SmarTrend Watching for Potential Rebound in Shares of Vertex Pharmaceuticals After 2.97% Loss

Comtex SmarTrend(R) - Wed Apr 24, 3:52PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $78.78 to a high of $81.56. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $80.10 on volume of 4.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story)

After Yesterday's Decline of 2.97%, Vertex Pharmaceuticals Offers Investors Better Value

Comtex SmarTrend(R) - Wed Apr 24, 3:51PM CDT
Vertex Pharmaceuticals (NASDAQ:VRTX) traded in a range yesterday that spanned from a low of $78.78 to a high of $81.56. Yesterday, the shares fell 3.0%, which took the trading range below the 3-day low of $80.10 on volume of 4.4 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story)

Shares of VRTX Up 82.1% Since Uptrend Call on Shares

Comtex SmarTrend(R) - Wed Apr 24, 9:30AM CDT
SmarTrend identified an Uptrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on January 3rd, 2013 at $44.30. In approximately 4 months, Vertex Pharmaceuticals has returned 82.12% as of today's recent price of $80.68. (full story)
*Older Stories